Home Markets Gastric Ulcers Pipeline And Therapeutics Development 2017

Gastric Ulcers Pipeline And Therapeutics Development 2017

10
SHARE
Gastric Ulcers – Pipeline Review, H1 2017

Gastric Ulcers Pipeline provides comprehensive information on the therapeutics under development for Gastric Ulcers (Gastrointestinal), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Gastric Ulcers (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Gastric Ulcers and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase I and Preclinical stages are 1, 5 and 5 respectively.

Get this research report at https://www.marketinsightsreports.com/reports/041311732/gastric-ulcers-pipeline-and-therapeutics-development-h1-2017

Companies discussed in this research are Astellas Pharma Inc, Boryung Pharmaceutical Co Ltd, ChoDang Pharm Co Ltd, Daewoong Pharmaceutical Co Ltd, Kukje Pharmaceutical Industry Co Ltd, RaQualia Pharma Inc and XuanZhu Pharma Co Ltd.

Drug Profiles mentioned are (lafutidine + irsogladine maleate), anaprazole sodium, ASP-6537, BGC-001, cholesteryl glucoside, DWJ-1386, DWJ-206, DWP-14012, KJ-14001, Small Molecules for Gastric Ulcers and tegoprazan.

Gastric Ulcers (Gastrointestinal) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Inquire more on this research at https://www.marketinsightsreports.com/reports/041311732/gastric-ulcers-pipeline-and-therapeutics-development-h1-2017/inquiry

Scope of this research covers the pipeline guide provides a snapshot of the global therapeutic landscape of Gastric Ulcers (Gastrointestinal). The pipeline guide reviews pipeline therapeutics for Gastric Ulcers (Gastrointestinal) by companies and universities/research institutes based on information derived from company and industry-specific sources. The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages. The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities. The pipeline guide reviews key companies involved in Gastric Ulcers (Gastrointestinal) therapeutics and enlists all their major and minor projects. The pipeline guide evaluates Gastric Ulcers (Gastrointestinal) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. The pipeline guide encapsulates all the dormant and discontinued pipeline projects. The pipeline guide reviews latest news related to pipeline therapeutics for Gastric Ulcers (Gastrointestinal).

List of Tables

  • Number of Products under Development for Gastric Ulcers, H1 2017
  • Number of Products under Development by Companies, H1 2017
  • Products under Development by Companies, H1 2017
  • Number of Products by Stage and Target, H1 2017
  • Number of Products by Stage and Mechanism of Action, H1 2017
  • Number of Products by Stage and Route of Administration, H1 2017
  • Number of Products by Stage and Molecule Type, H1 2017
  • Gastric Ulcers – Pipeline by Astellas Pharma Inc, H1 2017
  • Gastric Ulcers – Pipeline by Boryung Pharmaceutical Co Ltd, H1 2017
  • Gastric Ulcers – Pipeline by ChoDang Pharm Co Ltd, H1 2017
  • Gastric Ulcers – Pipeline by Daewoong Pharmaceutical Co Ltd, H1 2017
  • Gastric Ulcers – Pipeline by Kukje Pharmaceutical Industry Co Ltd, H1 2017
  • Gastric Ulcers – Pipeline by RaQualia Pharma Inc, H1 2017
  • Gastric Ulcers – Pipeline by XuanZhu Pharma Co Ltd, H1 2017
  • Gastric Ulcers – Dormant Projects, H1 2017
  • Gastric Ulcers – Discontinued Products, H1 2017 List of Figures
  • Number of Products under Development for Gastric Ulcers, H1 2017
  • Number of Products under Development by Companies, H1 2017
  • Number of Products by Targets, H1 2017
  • Number of Products by Stage and Targets, H1 2017
  • Number of Products by Mechanism of Actions, H1 2017
  • Number of Products by Stage and Mechanism of Actions, H1 2017
  • Number of Products by Stage and Routes of Administration, H1 2017
  • Number of Products by Stage and Molecule Types, H1 2017

LEAVE A REPLY

Please enter your comment!
Please enter your name here